Patents by Inventor Ayala POLLACK

Ayala POLLACK has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions and methods for treatment of retinal degenerative diseases
    Patent number: 10682328
    Abstract: This disclosure relates to compositions for use in treatment of Alzheimer's Disease, and/or a ocular and retinal degenerative disease, such as age related macular degeneration. The described compositions include effective amounts of LLMe, the hydrobromide form thereof, or functional derivatives thereof. Methods of treatment of a retinal degenerative disease of Alzheimer's Disease using the described compositions are also provided.
    Type: Grant
    Filed: December 3, 2015
    Date of Patent: June 16, 2020
    Assignee: MOR RESEARCH APPLICATIONS LTD.
    Inventors: Zeev Dvashi, Ayala Pollack
  • Treatments for fibrotic diseases
    Patent number: 10206900
    Abstract: Disclosed herein are methods for treatment for fibrosis, ocular pathologies associated with fibrosis, including proliferative vitreoretinopathy (PVR) by inhibiting the activity of activated transforming growth factor ? activated kinase 1 (TAK1), or activation thereof. Pharmaceutical compositions for use in the described treatments are also provided.
    Type: Grant
    Filed: March 29, 2016
    Date of Patent: February 19, 2019
    Assignee: Mor Research Applications Ltd.
    Inventors: Ayala Pollack, Zeev Dvashi
  • Compositions and methods for treatment of retinal degenerative diseases
    Patent number: 9878021
    Abstract: This disclosure relates to compositions for use in treatment of a retinal degenerative disease, such as age related macular degeneration. The described compositions include agents for activating p38 and/or JNK signaling through the activation of TAK1 in the retinal pigment epithelium of a subject diagnosed with the disease. Methods of treatment of a retinal degenerative disease using the described compositions are also provided.
    Type: Grant
    Filed: May 29, 2014
    Date of Patent: January 30, 2018
    Assignee: MOR RESEARCH APPLICATIONS LTD.
    Inventors: Ayala Pollack, Zeev Dvashi
  • COMPOSITIONS AND METHODS FOR TREATMENT OF RETINAL DEGENERATIVE DISEASES
    Publication number: 20170266146
    Abstract: This disclosure relates to compositions for use in treatment of Alzheimer's Disease, and/or a ocular and retinal degenerative disease, such as age related macular degeneration. The described compositions include effective amounts of LLMe, the hydrobromide form thereof, or functional derivatives thereof. Methods of treatment of a retinal degenerative disease of Alzheimer's Disease using the described compositions are also provided.
    Type: Application
    Filed: December 3, 2015
    Publication date: September 21, 2017
    Applicant: MOR RESEARCH APPLICATIONS LTD.
    Inventors: Zeev DVASHI, Ayala POLLACK
  • TREATMENTS FOR FIBROTIC DISEASES
    Publication number: 20160206591
    Abstract: Disclosed herein are methods for treatment for fibrosis, ocular pathologies associated with fibrosis, including proliferative vitreoretinopathy (PVR) by inhibiting the activity of activated transforming growth factor ? activated kinase 1 (TAK1), or activation thereof. Pharmaceutical compositions for use in the described treatments are also provided.
    Type: Application
    Filed: March 29, 2016
    Publication date: July 21, 2016
    Applicant: MOR RESEARCH APPLICATIONS LTD.
    Inventors: Ayala Pollack, Zeev Dvashi
  • COMPOSITIONS AND METHODS FOR TREATMENT OF RETINAL DEGENERATIVE DISEASES
    Publication number: 20160114006
    Abstract: This disclosure relates to compositions for use in treatment of a retinal degenerative disease, such as age related macular degeneration. The described compositions include agents for activating p38 and/or JNK signaling through the activation of TAK1 in the retinal pigment epithelium of a subject diagnosed with the disease. Methods of treatment of a retinal degenerative disease using the described compositions are also provided.
    Type: Application
    Filed: May 29, 2014
    Publication date: April 28, 2016
    Applicant: MOR RESEARCH APPLICATIONS LTD.
    Inventors: Ayala POLLACK, Zeev DVASHI